JP2011509650A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509650A5
JP2011509650A5 JP2010526077A JP2010526077A JP2011509650A5 JP 2011509650 A5 JP2011509650 A5 JP 2011509650A5 JP 2010526077 A JP2010526077 A JP 2010526077A JP 2010526077 A JP2010526077 A JP 2010526077A JP 2011509650 A5 JP2011509650 A5 JP 2011509650A5
Authority
JP
Japan
Prior art keywords
ferm
item
antibody
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010526077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509650A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/050606 external-priority patent/WO2009088105A1/en
Publication of JP2011509650A publication Critical patent/JP2011509650A/ja
Publication of JP2011509650A5 publication Critical patent/JP2011509650A5/ja
Pending legal-status Critical Current

Links

JP2010526077A 2008-01-11 2009-01-13 ヒト化抗−α９インテグリン抗体及びその使用 Pending JP2011509650A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2052708P 2008-01-11 2008-01-11
PCT/JP2009/050606 WO2009088105A1 (en) 2008-01-11 2009-01-13 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF

Publications (2)

Publication Number Publication Date
JP2011509650A JP2011509650A (ja) 2011-03-31
JP2011509650A5 true JP2011509650A5 (enExample) 2012-02-09

Family

ID=40853211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010526077A Pending JP2011509650A (ja) 2008-01-11 2009-01-13 ヒト化抗−α９インテグリン抗体及びその使用

Country Status (8)

Country Link
US (1) US8821863B2 (enExample)
EP (2) EP2245156A4 (enExample)
JP (1) JP2011509650A (enExample)
KR (1) KR101597842B1 (enExample)
CN (1) CN101918555B (enExample)
AU (1) AU2009203350B2 (enExample)
CA (1) CA2711771C (enExample)
WO (1) WO2009088105A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657133C (en) * 2006-07-12 2017-04-11 Gene Techno Science Co., Ltd. Anti-human .alpha.9 integrin antibody and use of the same
CN102333791B (zh) * 2009-03-10 2014-06-25 株式会社遗传科技 人源化k33n单克隆抗体的生成、表达和表征
WO2011004847A1 (ja) * 2009-07-07 2011-01-13 一般財団法人化学及血清療法研究所 新規ヒト化抗ヒトα９インテグリン抗体
AU2013293570B2 (en) 2012-07-27 2019-05-23 City Of Hope An MVA vaccine for delivery of a UL128 complex and preventing CMV infection
WO2014083379A1 (en) * 2012-11-30 2014-06-05 Institut Pasteur Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
TWI700300B (zh) * 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
ES2924071T3 (es) * 2015-09-02 2022-10-04 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Anticuerpos específicos para inmunoglobulina de células T humanas y dominio ITIM (TIGIT)
WO2017044895A2 (en) 2015-09-10 2017-03-16 City Of Hope MVA-gH/gL-PC VACCINE DERIVED ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS INFECTIVITY AND METHODS THEREOF
CA3101641A1 (en) 2018-06-04 2019-12-12 Intrexon Corporation Muc16 specific chimeric antigen receptors and uses thereof
CN117285619B (zh) * 2023-09-28 2025-11-25 广西壮族自治区兽医研究所 一种鸡细小病毒的单克隆抗体及其应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
AU600575B2 (en) 1987-03-18 1990-08-16 Sb2, Inc. Altered antibodies
US5258498A (en) 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
WO1989007142A1 (en) 1988-02-05 1989-08-10 Morrison Sherie L Domain-modified constant region antibodies
EP1997891A1 (en) 1988-09-02 2008-12-03 Dyax Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
WO1991010737A1 (en) 1990-01-11 1991-07-25 Molecular Affinities Corporation Production of antibodies using gene libraries
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5314995A (en) 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
WO1992022324A1 (en) 1991-06-14 1992-12-23 Xoma Corporation Microbially-produced antibody fragments and their conjugates
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
ATE408012T1 (de) 1991-12-02 2008-09-15 Medical Res Council Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
ZA932522B (en) 1992-04-10 1993-12-20 Res Dev Foundation Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
EP0749475A4 (en) 1992-08-26 1997-05-07 Harvard College USE OF CYTOKINE IP-10 AS ANTI-TUMOR AGENT
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
WO1994029351A2 (en) 1993-06-16 1994-12-22 Celltech Limited Antibodies
WO1995015982A2 (en) 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies
DK1231268T3 (da) 1994-01-31 2005-11-21 Univ Boston Polyklonale antistofbiblioteker
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
KR100881900B1 (ko) 2001-04-05 2009-02-04 가부시키가이샤 멘에키세이부츠 켄큐죠 항-오스테오폰틴 항체 및 그 용도
WO2003105782A2 (en) * 2002-06-17 2003-12-24 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Specificity grafting of a murine antibody onto a human framework
ITRM20030601A1 (it) * 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
JPWO2006013904A1 (ja) * 2004-08-03 2008-05-01 持田製薬株式会社 メルトリンアンタゴニストを含有する医薬組成物
JP4871740B2 (ja) 2005-01-13 2012-02-08 株式会社ジーンテクノサイエンス 抗α９インテグリン抗体とその用途
CA2657133C (en) * 2006-07-12 2017-04-11 Gene Techno Science Co., Ltd. Anti-human .alpha.9 integrin antibody and use of the same

Similar Documents

Publication Publication Date Title
JP2011509650A5 (enExample)
JP2013198490A5 (enExample)
WO2013037484A3 (en) Anti-aplhabetatcr antibody
BRPI0908508A2 (pt) anticorpo monoclonal nkg2a anti-humano humanizado
WO2009120927A3 (en) Methods of treatment
NZ604643A (en) S100a4 antibodies and therapeutic uses thereof
IL197928A (en) A monoclonal antibody munched on steap-1, its immunoconjugates its uses
NZ602294A (en) Monoclonal antibodies against c-met
IL202232A (en) A method of making a human antibody derived from a rabbit parent antibody that binds to a desired antigen as well as a human antibody or fragment thereof produced by this method
NZ616382A (en) Antibodies specific to cadherin-17
HRP20140266T1 (hr) Postupci inhibiranja vezanja endosijalina na ligande
RU2017128882A (ru) Антитела к биотину и способы их применения
WO2008043145A8 (en) Hybridomas producing antibodies against non functional p2x7 receptor
ZA200905447B (en) Multivariable antigens complexed with targeting humanized monoclonal antibody
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
JP2016520514A5 (enExample)
NZ592214A (en) Improved Interleukin-6 receptor antibody molecule
PH12012501525A1 (en) A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
JP2010513228A5 (enExample)
SG178886A1 (en) Humanized anti-cdcp1 antibodies
EP2233501A4 (en) HUMANIZED MONOCLONAL ANTI-CD34 ANTIBODIES AND THEIR PREPARATION AND APPLICATIONS
JP2010509937A5 (enExample)
NZ595863A (en) Antibodies to egfl7 and methods for their use
JP2011237442A5 (enExample)
ES2570182T3 (es) Prevención y tratamiento de la enfermedad sinucleinopática y amiloidogénica